Analyze Diet

Development of IgM-ELISA for diagnosis of recent infection of Japanese encephalitis virus in equines.

Abstract: Japanese encephalitis (JE) is a re-emerging mosquito borne disease, for which equines are most susceptible amongst all animals. Detection of specific immunoglobulin 'M' (IgM) is considered as an ideal way to diagnose recent JE virus infection in equines due to low virus load and short-term viremia. The present study was undertaken to develop a sensitive and specific recombinant NS1 protein based indirect IgM-ELISA and IgM capture (MAC) ELISA to diagnose recent infection of JEV in equines. Indirect IgM ELISA was standardized with relative diagnostic sensitivity and specificity of 100% and 88.5%, respectively. The validation of indirect IgM-ELISA in different laboratories revealed excellent reproducibility with Cohen's kappa value ranging between 0.84 and 1. The standardization of MAC ELISA was attempted using checker board titration method and non-specific binding of polyclonal anti-equine IgM capture antibody with anti-porcine IgG conjugate and with hyperimmune serum raised in swine against the antigen was observed. Hence, the MAC ELISA was standardized with monoclonal capture antibody; however, its diagnostic performance could not meet the satisfactory limit. Due to better sensitivity and less turnaround time, indirect IgM-ELISA was employed to screen 821 equine serum samples revealing 33.73% positivity of IgM antibodies against JEV in equine population of India. The high JEV sero-positivity warrants the need for vaccination in Indian equine population along with the demand for research focused towards anti-viral therapy. The indirect IgM-ELISA developed in the present study could be useful to diagnose acute or recent infection of JEV in equines as well as in sero-epidemiological studies.
Publication Date: 2022-01-15 PubMed ID: 35042674DOI: 10.1016/j.biologicals.2022.01.001Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research aimed to establish a highly sensitive diagnostic tool, specifically IgM-ELISA, for early detection of the Japanese encephalitis virus (JEV) in horses, a prevalent mosquito-borne disease with a high infection rate in Indian equines.

Development of IgM-ELISA Diagnostic Tool for JEV

  • The researchers focused on detecting specific immunoglobulin ‘M’ (IgM) in horses, since it serves as a signifier of recent JEV infection. They aimed to build a sensitive and specific recombinant NS1 protein-based indirect IgM-ELISA and IgM capture (MAC) ELISA diagnostic tools.
  • The indirect IgM ELISA they developed showed excellent diagnostic sensitivity and specificity of 100% and 88.5%, respectively. Various laboratories validated its reproducibility with a high Cohen’s kappa value range of 0.84 to 1. This suggests that the test provides consistent, reliable results across different settings.

Challenges in Standardizing MAC ELISA

  • While trying to standardize MAC ELISA using the checker board titration method, the researchers observed unwanted binding of polyclonal anti-equine IgM capture antibody with anti-porcine IgG conjugate and with hyperimmune serum made in swine against the antigen. This highlighted the need to use monoclonal capture antibody.
  • However, the performance of MAC ELISA, even when standardized with the monoclonal antibody, did not meet satisfactory limits, indicating its potential ineffectiveness as a diagnostic tool for JEV in horses.

Screening and Implications for Equine Healthcare

  • The researchers employed the more efficient IgM-ELISA to screen 821 equine serum samples, out of which they discovered a 33.73% positivity rate of IgM antibodies against JEV in Indian horse populations.
  • The high seropositivity to JEV underscores the necessity for vaccinations, as well as research focused on antiviral therapy for the equine population in India.
  • The successful development of indirect IgM-ELISA provides a vital tool not only for diagnosing acute or recent infection of JEV in horses, but also in conducting sero-epidemiological studies on the spread and control of the disease.

Cite This Article

APA
Sahu A, Dhanze H, Singh V, Mehta D, Gupta M, Singh M, Vinod VK, Gulati BR. (2022). Development of IgM-ELISA for diagnosis of recent infection of Japanese encephalitis virus in equines. Biologicals, 75, 16-20. https://doi.org/10.1016/j.biologicals.2022.01.001

Publication

ISSN: 1095-8320
NlmUniqueID: 9004494
Country: England
Language: English
Volume: 75
Pages: 16-20
PII: S1045-1056(22)00001-X

Researcher Affiliations

Sahu, Anamika
  • ICAR-Indian Veterinary Research Institute, Bareilly, India.
Dhanze, Himani
  • ICAR-Indian Veterinary Research Institute, Bareilly, India. Electronic address: hdhanze@yahoo.co.in.
Singh, Vijayta
  • ICAR-Indian Veterinary Research Institute, Bareilly, India.
Mehta, Deepa
  • ICAR-Indian Veterinary Research Institute, Bareilly, India.
Gupta, Megha
  • ICAR-Indian Veterinary Research Institute, Bareilly, India.
Singh, Mithilesh
  • ICAR-Indian Veterinary Research Institute, Bareilly, India.
Vinod, V K
  • ICAR-Indian Veterinary Research Institute, Bareilly, India.
Gulati, B R
  • ICAR-National Research Centre on Equines, Hisar, India.

MeSH Terms

  • Animals
  • Antibodies, Viral
  • Encephalitis Virus, Japanese
  • Encephalitis, Japanese / diagnosis
  • Encephalitis, Japanese / veterinary
  • Enzyme-Linked Immunosorbent Assay / methods
  • Enzyme-Linked Immunosorbent Assay / veterinary
  • Horses
  • Immunoglobulin M
  • Reproducibility of Results
  • Swine

Citations

This article has been cited 1 times.
  1. Han L, An C, Liu D, Wang Z, Bian L, He Q, Liu J, Wang Q, Liu M, Mao Q, Hang T, Wang A, Gao F, Tan D, Liang Z. Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content.. Viruses 2022 Dec 24;15(1).
    doi: 10.3390/v15010062pubmed: 36680102google scholar: lookup